WO2007148092A8 - In vitro protein expression process comprising cκ fusion molecules - Google Patents
In vitro protein expression process comprising cκ fusion molecules Download PDFInfo
- Publication number
- WO2007148092A8 WO2007148092A8 PCT/GB2007/002309 GB2007002309W WO2007148092A8 WO 2007148092 A8 WO2007148092 A8 WO 2007148092A8 GB 2007002309 W GB2007002309 W GB 2007002309W WO 2007148092 A8 WO2007148092 A8 WO 2007148092A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- protein expression
- vitro protein
- expression process
- fusion molecules
- gene encoding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3007—Carcino-embryonic Antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07733308A EP2029764A2 (en) | 2006-06-21 | 2007-06-21 | In vitro protein expression process comprising c fusion molecules |
GB0822625A GB2452201A (en) | 2006-06-21 | 2007-06-21 | In vitro protein expression process comprising Ck fusion molecules |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0612223.8 | 2006-06-21 | ||
GB0612223A GB0612223D0 (en) | 2006-06-21 | 2006-06-21 | Ck fusion molecules |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2007148092A2 WO2007148092A2 (en) | 2007-12-27 |
WO2007148092A3 WO2007148092A3 (en) | 2008-02-07 |
WO2007148092A8 true WO2007148092A8 (en) | 2009-07-16 |
Family
ID=36803566
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2007/002309 WO2007148092A2 (en) | 2006-06-21 | 2007-06-21 | In vitro protein expression process comprising cκ fusion molecules |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2029764A2 (en) |
GB (2) | GB0612223D0 (en) |
WO (1) | WO2007148092A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9937239B2 (en) | 2014-05-21 | 2018-04-10 | The Johns Hopkins University | Preservation and reconstitution of cell-free protein expression systems |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2063035A1 (en) * | 1991-03-27 | 1992-09-28 | Klaus Karjalainen | Chimaeric antibodies containing the ligand domain of cd4 |
EP1732946B1 (en) * | 2004-03-08 | 2011-07-27 | ZymoGenetics, Inc. | Dimeric fusion proteins and materials and methods for producing them |
-
2006
- 2006-06-21 GB GB0612223A patent/GB0612223D0/en not_active Ceased
-
2007
- 2007-06-21 WO PCT/GB2007/002309 patent/WO2007148092A2/en active Application Filing
- 2007-06-21 EP EP07733308A patent/EP2029764A2/en not_active Withdrawn
- 2007-06-21 GB GB0822625A patent/GB2452201A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB0612223D0 (en) | 2006-08-02 |
WO2007148092A3 (en) | 2008-02-07 |
GB2452201A (en) | 2009-02-25 |
WO2007148092A2 (en) | 2007-12-27 |
GB0822625D0 (en) | 2009-01-21 |
EP2029764A2 (en) | 2009-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008140582A3 (en) | Production of anti-microbial peptides | |
DK1716178T3 (en) | Less immunogenic binding molecules | |
WO2008098100A3 (en) | Detection of molecule proximity | |
WO2008074867A3 (en) | Anti-fc-receptor single domain antibodies (nanobodies-tm) and therapeutic use | |
WO2006131928A3 (en) | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis | |
WO2008132568A3 (en) | Fusion proteins binding to growth factors | |
WO2007070432A3 (en) | Binding proteins specific for insulin-like growth factors and uses thereof | |
WO2007146038A3 (en) | Albumin fusion proteins | |
WO2010129304A3 (en) | Method for making heteromultimeric molecules | |
WO2006034332A3 (en) | In vivo incorporation of alkynyl amino acids into proteins in eubacteria | |
IL209350A0 (en) | Anti -a?? globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies | |
WO2009026393A3 (en) | Amino acid substituted molecules | |
EA200700917A1 (en) | REFOLDING METHOD FOR RECOMBINANT ANTIBODIES | |
WO2008048545A3 (en) | Molecules with reduced half-lives, compositions and uses thereof | |
WO2006119107A3 (en) | Sclerostin binding agents | |
WO2006119062A3 (en) | Sclerostin epitopes | |
EP2395091A3 (en) | Plants having enhanced yield-related traits and a method for making the same | |
WO2008143679A9 (en) | Nucleic acids and proteins and methods for making and using them | |
WO2006068953A3 (en) | Antibodies directed to angiopoietin-2 and uses thereof | |
WO2008036688A3 (en) | Optimized antibodies that target hm1.24 | |
WO2005116237A3 (en) | Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination | |
WO2007039903A3 (en) | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis | |
WO2006113475A3 (en) | Methods and compositions to modulate adhesion and stress tolerance in bacteria | |
WO2008036392A3 (en) | Genetically programmed expression of selectively sulfated proteins in eubacteria | |
WO2005110067A3 (en) | Method and compositions for rna interference |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07733308 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007733308 Country of ref document: EP |
|
ENP | Entry into the national phase in: |
Ref document number: 0822625 Country of ref document: GB Kind code of ref document: A Free format text: PCT FILING DATE = 20070621 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 0822625.0 Country of ref document: GB |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
NENP | Non-entry into the national phase in: |
Ref country code: RU |